Comment on CMS-2026-1256-0002
Novant HealthOtherBusiness
Summary: Novant Health, a healthcare network, provides mixed feedback on the proposed rule. They oppose the repeal of the New Technology Add-on Payment (NTAP) Alternative Pathway and the accelerated timeline for the Sepsis Readmission Measure, but they support the proposed mortality measure specification changes in the Hospital Value-Based Purchasing (HVBP) Program.
Please see the attached comment from Novant Health in response to the FY 2027 IPPS final rule (CMS-1849-P).